Author: OurCrowd

[Babson Diagnostics in PR Newswire] Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

May 11, 2022 |

AUSTIN, Texas and FRANKLIN LAKES, N.J., May 11, 2022 /PRNewswire/ — Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Read...

Read More

[SaNOtize in Business Wire] Clinical study suggests SaNOtize nitric oxide nasal spray is effective at preventing COVID-19 after high-risk exposure

May 11, 2022 | ,

VANCOUVER, British Columbia–(BUSINESS WIRE)–SaNOtize Research and Development (“SaNOtize”) today announced results from a retrospective clinical study assessing the efficacy of nitric oxide releasing nasal spray (NONS™) in preventing COVID-19 infection after high-risk exposure. Nitric oxide is a naturally occurring molecule known to have antimicrobial properties, including a direct effect on SARS-CoV-2 and its variants, the virus that causes COVID-19. The new study, conducted at Srinakharinwirot University in Bangkok, Thailand, found participants who took NONS after COVID-19 exposure were 75% less likely to become infected when compared to the control group, yielding a statistically significant reduction in infection rate. Read more...

Read More